Natasha J Williams1, Girardin Jean-Louis2, Joeseph Ravenell2, Azizi Seixas2, Nadia Islam3, Chau Trinh-Shevrin3, Gbenga Ogedegbe2. 1. Center for Healthful Behavior Change, Division of Health and Behavior, Department of Population Health, NYU Medical Center, New York, NY 10016, USA. Electronic address: Natasha.williams2@nyumc.org. 2. Center for Healthful Behavior Change, Division of Health and Behavior, Department of Population Health, NYU Medical Center, New York, NY 10016, USA. 3. Center for Health Equity, Division of Health and Behavior, Department of Population Health, NYU Medical Center, New York, NY 10016, USA.
Abstract
OBJECTIVE: Obstructive sleep apnea (OSA) is a leading sleep disorder that is disproportionately more prevalent in minority populations and is a major risk factor for cardiovascular disease (CVD) morbidity and mortality. OSA is associated with many chronic conditions including hypertension, diabetes, and obesity, all of which are disproportionately more prevalent among blacks (ie, peoples of African American, Caribbean, or African descent). METHODS: This article reviews studies conducted in the United States (US) that investigated sleep screenings and adherence to treatment for OSA among blacks. In addition, guidelines are provided for implementing a practical framework to increase OSA screening and management among blacks. RESULTS: Several studies have documented racial/ethnic disparities in adherence to treatment for OSA. However, despite its public health significance, there is a paucity of studies addressing these disparities. Further, there is a lack of health programs and policies to increase screening and treatment of OSA among blacks and other minority populations. A practical framework to increase the number of blacks who are screened for OSA and treated appropriately is warranted. Such a framework is timely and major importance, as early identification of OSA in this high-risk population could potentially lead to early treatment and prevention of CVD, thereby reducing racial and ethnic disparities in sleep-related CVD morbidity and mortality.
OBJECTIVE:Obstructive sleep apnea (OSA) is a leading sleep disorder that is disproportionately more prevalent in minority populations and is a major risk factor for cardiovascular disease (CVD) morbidity and mortality. OSA is associated with many chronic conditions including hypertension, diabetes, and obesity, all of which are disproportionately more prevalent among blacks (ie, peoples of African American, Caribbean, or African descent). METHODS: This article reviews studies conducted in the United States (US) that investigated sleep screenings and adherence to treatment for OSA among blacks. In addition, guidelines are provided for implementing a practical framework to increase OSA screening and management among blacks. RESULTS: Several studies have documented racial/ethnic disparities in adherence to treatment for OSA. However, despite its public health significance, there is a paucity of studies addressing these disparities. Further, there is a lack of health programs and policies to increase screening and treatment of OSA among blacks and other minority populations. A practical framework to increase the number of blacks who are screened for OSA and treated appropriately is warranted. Such a framework is timely and major importance, as early identification of OSA in this high-risk population could potentially lead to early treatment and prevention of CVD, thereby reducing racial and ethnic disparities in sleep-related CVD morbidity and mortality.
Authors: Emma K Larkin; Sanjay R Patel; Robert J Goodloe; Yali Li; Xiaofeng Zhu; Courtney Gray-McGuire; Mark D Adams; Susan Redline Journal: Am J Respir Crit Care Med Date: 2010-06-10 Impact factor: 21.405
Authors: Martha E Billings; Dennis Auckley; Ruth Benca; Nancy Foldvary-Schaefer; Conrad Iber; Susan Redline; Carol L Rosen; Phyllis Zee; Vishesh K Kapur Journal: Sleep Date: 2011-12-01 Impact factor: 5.849
Authors: Nancy A Collop; W McDowell Anderson; Brian Boehlecke; David Claman; Rochelle Goldberg; Daniel J Gottlieb; David Hudgel; Michael Sateia; Richard Schwab Journal: J Clin Sleep Med Date: 2007-12-15 Impact factor: 4.062
Authors: Daniel J Levendowski; Todd Morgan; Jon Montague; Victoria Melzer; Chris Berka; Philip R Westbrook Journal: Sleep Breath Date: 2008-04-09 Impact factor: 2.816
Authors: Natasha T Giddens; Paul Juneau; Peter Manza; Corinde E Wiers; Nora D Volkow Journal: Proc Natl Acad Sci U S A Date: 2022-07-18 Impact factor: 12.779
Authors: Diana M Rosenthal; Donaldson F Conserve; Dodley Severe; Michaele A Gedeon; Ferdinand Zizi; Georges Casimir; Samy I McFarlane; Girardin Jean-Louis Journal: J Sleep Disord Ther Date: 2017-04-25